Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07738978

Understanding and Enhancing Human Health and Movement

By doing this study, investigators hope to learn how electrical stimulation can improve human movement, biomechanics, and function and to gather information on the safety and effectiveness of an implanted electrical stimulation system after paralysis from spinal cord injury, stroke, multiple sclerosis, and traumatic brain injury.

Recruiting

Interested in participating?

Request Info

Key information

About this study

The purpose of this research study is to better understand how people move, so investigators can develop improved ways to help individuals with lower-limb and/or trunk paralysis perform everyday activities such as sitting, reaching, pushing a wheelchair, transferring, standing, stepping, and maintaining balance.

This study evaluates how activating stabilizing muscles, either with surface electrical stimulation or with an implanted neural stimulation device may change the way these daily activities are performed and potentially enhance functional independence.

A key goal of this project is to collect information on the safety and effectiveness of an implanted neural stimulation system. The U.S. Food and Drug Administration (FDA) permits the limited investigational use of this implanted system for individuals with lower-limb and/or trunk paralysis resulting from neurological conditions.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Skeletal maturity and ability to sign informed consent (>18 years)
  • Non-ventilator dependent paralysis resulting from injuries such as: mid cervical/thoracic (C4 or below) spinal cord injuries, poststroke hemiparesis, TBI, or MS, affecting the trunk and/or lower limbs
  • Innervated and excitable lower extremity and trunk musculature
  • Adequate social support and stability
  • Willingness to comply with follow-up procedures
  • Time post injury greater than six months
  • Appropriate body habitus (height and weight within acceptable limits as determined by study physician)
  • Neurologically stable as determined by a physician

Exclusion criteria

  • Non-English speaking
  • Females who are pregnant
  • Current pressure injuries that would be exacerbated by study activities
  • Severe contractures or uncontrolled spasticity of any major joint of the upper or lower extremities that results in a fixed deformity that would interfere with study activities
  • History of spontaneous fractures or other evidence of excessively low bone density
  • History of vestibular dysfunction, balance problems, or spontaneous falls
  • Acute and or/untreated orthopedic problems that would prevent a participant from weight bearing or exercising such as a dislocation or fracture.
  • Acute and/or chronic problems left untreated or not controlled that would put a participant at risk by using stimulation such as cardiac abnormalities, immunological/pulmonary/renal/circulatory compromise, diabetes or hypertension
  • Presence of a demand pacemaker or cardiac defibrillator
  • Any other medical or psychological condition that would be a contraindication
  • Current pressure ulcers
  • Significant range of motion limitations that would compromise study activities
  • Body habitus that would compromise study activities

Treatment and study plan

Neural Prosthesis

Device

implanted electrical stimulation device

Other names: IST-16, IST-12, IRS-8, Spiral Cuff

Primary outcomes

  1. Difference in Max Standing Time

    Time frame: Study completion - an average of 1 year

  2. Difference in Max Walking distance

    Time frame: Study completion - an average of 1 year

Study contacts

Contact information is provided by the study sponsor or research team.

Lisa Lombardo, MPT

CONTACT

[email protected]

2167913800 ext. 64909

Maura Malenchek, PTA

CONTACT

[email protected]

216-791-3800 ext. 64989

Sponsors and collaborators

Lead sponsor

Louis Stokes VA Medical Center

Fed

Registry information

Important dates

Study start
2021
Primary completion
2031
Study completion
2034
First posted
Jul 31, 2026
Registry last updated
Jul 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.